Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Department of Justice drops charges vs. FedEx in online pharmacy case

Published 06/17/2016, 05:44 PM
Updated 06/17/2016, 05:49 PM
© Reuters.  Federal prosecutors dropped charged against FedEx in a two-yr online pharmacy case on Friday

Investing.com -- FedEx Corporation (NYSE:FDX) announced on Friday afternoon that the U.S. Department of Justice has dismissed all remaining criminal charges pending against the company, signifying the conclusion of a two-year internet pharmacy case.

The announcement provides vindication for the major shipping company, which maintained its innocence through a two-year ordeal in which FedEx faced up to $1.6 billion in fines for money laundering and conspiracy related to its assistance with drug deliveries for rogue online pharmacies. As part of the charges, FedEx was accused of accepting payments from several pharmacies when several senior managers from the company allegedly knew that the pharmacies supplied drugs to their customers without prescriptions. At a pre-trial hearing in late-May, U.S. district judge Charles Breyer expressed skepticism that prosecutors had sufficient proof that FedEx intended for the drugs to be distributed illegally.

Lawyers for FedEx argued that it was the government's burden to inform the company which pharmacies had acted illegally.

"FedEx is and has always been innocent,” said Patrick Fitzgerald, Senior Vice President, Marketing and Communications, FedEx, in a statement. “The case should never have been brought. The government should take a very hard look at how they made the tremendously poor decision to file these charges. Many companies would not have had the courage or the resources to defend themselves against false charges. The power of the government was greatly misused when the case was initiated, but the government’s integrity was redeemed by the decision to dismiss the charges today."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In 2013, UPS agreed to forfeit $40 million to the Justice Department for payments the company received from online pharmacies shipping illegal prescriptions. Two major pharmacy chains, CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance Inc (NASDAQ:WBA) have also paid settlements amounting to $150 million combined in recent years to resolve charges that they sold prescriptions which did not have an actual therapeutic use.

FedEx remains committed to its long-standing cooperation with law enforcement authorities to prevent misuse of its transportation networks, the company said in a statement.

Shares in FedEx closed on Friday at 162.25, up 0.38 or 0.23% for the session.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.